Evaluation of lipid profile and oxidative stress in STZ-induced rats treated with antioxidant vitamin

Brazilian Archives of Biology and Technology

Volumn 55, Issue 4, 2012, Pages 527-536

  Almeida, Danielle Ayr Tavares ^a   Braga, Camila Pereira ^b   Novelli, Ethel Lourenzi Barbosa ^b   Fernandes, Ana Angélica Henrique ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Lipid profile; Oxidative stress; STZ; Vitamin E

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 84866485728     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132012000400007     Document Type: Article

References (67)

1. Ahmed RG. The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system. Med. J. Islamic World Academy Sci. 2005; 15: 31-42.
2. Baydas G, Canatan H, Turkoglu A. (Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J. Pineal Res. 2002; 32: 225-230.
3. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre, J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab., 2000; 26: 162-76.
4. Bonnefont-Rousselot, D. The role of antioxidant Micronutrients in the Prevention of Diabetic Complications. Treat. Endocrinol. 2004; 3: 41-52.
5. Bray TM. Dietary Antioxidants and Assessment of Oxidative Stress. Nutr. 2000; 16: 578-80.
6. Ceriello A, Morocutti A, Franceschina M, Quagliaro L, Moro M, Damante G, et al. Defective intracellular Antioxidant Enzyme Production in Type 1 Diabetic Patients With Nephropathy. Am. Diabetes Assoc. 2000; 49: 2170-7.
7. Chertow B, Edwards JC. Advances in Diabetes for the Milennium: Vitamins and Oxidant Stress in Diabetes and Its Complications. Medscape General Med. 2004; 6: 1-10.
8. Cho SY, Park JY, Park EM, Choi MS, Lee MK, Jeon SM, et al. Alteration of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extrct. Clin Chim Acta. 2002; 317: 109-17.
9. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoi antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res. 2005; 51: 117-23.
10. Crouch RK, Gandy SC, Kisey G. The inhibition of islet superoxide dismutase by diabetogenic drugs. Diabetes. 1981; 30: 235-41.
11. Cullen P, Eckardstein A, Souris S, Schulte H. Assmann G. Dyslipidaemia and cardiovascular risk in diabetes. Diabetes Obes. Metab. 1999; 1: 189-98.
12. Desco M C, Asensi M, Marquez R. Martinez-Valls J, Vento M, Pallardo FV, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 2002; 51: 1118-24.
13. Dias AS, Porawski M, Alonso M, Morroni N, Collado PS, González-Gallego J. Quercetin Decreases Oxidative Stress, NF-B Activation, and iNOS Overexpression in Liver of Streptozotocin-Induced Diabetic Rats. J. Nutr. 2005; 135: 2299-304.
14. Duarte J, Galisteo M. Ocete M A, Pérez-Vizcaino F. Zarzuelo A, Tamargo J. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats. Mol. Cell. Biochem. 2001; 221: 155-60.
15. Evelson P, Susemihl C, Villarreal I, Llesuy S, Rodríguez R, Peredo H, et al. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Annals Hepatol. 2005; 4: 115-20.
16. Fakher SH, Djalali M, Tabei SMB, Zeraati H, Javadi, E, Sadeghi M, et al. Effect of vitamins A, E, C and Omega-3 Fatty Acids on Lipid Peroxidation in Streptozotocin Induced Diabetic Rats. Iranian J. Publ. Health. 2007; 36: 58-63.
17. Franz MJ, Bantle J P, Beebe CA, Brunzell JD, Chiasson JL, Grag A. et al. Wheeler M. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Clin. Diabetes. 2002; 20: 53-64.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
19. Guo H, Saiga A, Sato M, Miyazawa I, Shibata M, Takahata Y. Antihyperglycaemic and Antioxidant Effect of Rutin, a Polyphenolic Flavonoid, in Streptozotocin-Induced Diabetic Rats. The Nordic Pharmacol. Soc. 2006; 98: 97-103.
20. Hamilton IMJ, Gilmore WS, Benzie IFF, Mulholland CW, Strain JJ. Interactions between vitamins C and E in human subjects. Br. J. Nutr. 2000; 84: 261-67.
21. Jain SK, Mcvic R, Jaramillo JJ. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids. 1978; 31: 87-90.
22. Jari AE, Karlstrom BE, Grangfeldt YE, Bjork I.E, Asp NGL, Vessby BOH. Improved glycaemic control and lipid profile and normalised fibrinolytic activity on a low-glycaemic index diet in type 2 diabtic patients. Diabetes Care. 1999; 22: 10-8.
23. Je HD, Shin CY, Park HS, Huh IH, Sohn UD. The comparison of vitamin C and vitamin E on the protein oxidation of diabetic rats. J. Auton. Pharm. 2001; 21: 231-36.
24. +2 in the presence of xylenol orange. Comparison with the TBNAassay and an iodometric method. Lipids. 1991; 24: 861-69.
25. Kakkar R, Kaira J, Mantha SV, Prasad K. Lipidperoxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 1995; 151: 113-9.
26. Kammlakkannan N. Prince P.S.M. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. The Nordic Pharmacol. Soc. 2006; 98: 97-103.
27. Kondo HU, Kiyose C, Ohmori R, Saito H. Tagughi C, Kishimoto Y. Improves Lipoprotein Metabolism in Humans. J. Nutr. Sci. Vitaminol. 2007; 53: 345-8.
28. Konen JC, Summerson JH, Kirk JK. Measurement feasibility of advanced glycated end-products from skin samples after antioxidant vitamin supplementation in patients with type 2 diabetes. J. Nutr. Health Aging. 2000; 4: 81-4.
29. Koo JR, Oviesi F, Vaziri N D. Antioxidant therapy potentiates anthihypertensive action of insulin in diabetes rats. Am. J. Hipertens. 2001; 14: 53-5.
30. Knekt P, Reunanen A, Marniemi J, Leino, A, Aromaa A. Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J. Intern. Med. 1999; 245: 99-102.
31. Mackness MI, Abbott, CA, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J. 1993; 29: 829-34.
32. Majithiya JB, Balaraman R. Time-Dependent Changes in Antioxidant Enzumes and Vascular Reactivity of Aorta in Streptozotocin-Induced Diabetic Rats Treated With Curcumin. J. Cardiovasc. Pharmacol. 2005; 46: 697-705.
33. Matheus ASM, Cobas RA, Gomes MB. Dislipidemias no diabetes melito tipo 1: abordagem atual. Arq. Bras. Endocrinol. Metab. 2008; 52: 334-9.
34. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: A Review. J. Biochem. Moll. Toxicol. 2002; 17: 24-38.
35. McGinley C, Shafat A, Donnelly AE. Does antioxidant vitamin supplementation protect against muscle damage? Sports Medicine. 2009; 39: 1011-32.
36. Merzouk S, Hichami A, Sari A, Madani S, Merzouk H, Berrouiguet, YA, Lenoir-Rousseaux et al. Impaired Oxidant/Antioxidant Status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. Gen. Physiol. Biophys. 2004; 23: 387-99.
37. Mendez JD, Balderas F. Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetes rats. Biochem. 2001; 83: 453-58.
38. Matkovics B. Effect of plant and animal lesions on superoxide dismutase activities. In: McCord G, Michelson AM, Fridovich I, editors. Superoxide and superoxide dismutase. New York: Academic Press, p. 501-15.
39. a. ed., São apulo: Atheneu, 1982.
40. Musalmah M, Fairuz A H, Gapor MT, Ngah WZW. Effect of vitamin E on plasma malondialdehyde, antioxidant enzyme levels and the rates of wound closures during wound healing in normal and diabetic rats. Asia Pacific J. Cli. Nutr. 2002; 11: 448-51.
41. Nakamura W, Hojoda S. Hayashi K. Purification and properties of rat liver glutatione peroxidase. Biochim. Biophys. Acta. 1974; 358: 251-61.
42. Postic C, Dentin R Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004; 30: 398-408.
43. Price KD, Price CSC, Reynolds RD. Hyperglycemiainduced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis. Atherosclerosis. 2001; 158: 1-12.
44. Punitha ISR, Rajendran K, Shirwaikar A, Shirwaikar A. Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. ECAM. 2005; 2: 375-81.
45. Punithavathi VR, Anuthama R, Prince PS. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male wistar rats. J.Appl. Toxicol. 2008; 28: 806-13.
46. Ramesh B, Pugalendi KV. Impact of umbelliferone on erythrocyte redox status in STZ-diabetic rats. Yale J. Biol. Med. 2005; 78: 131-8.
47. Ramkumar KM, Rajaguru P, Latha M., Ananthan, R. Effect of Gymnema montanum leaves on red blood cell resistence to oxidative stress in experimental diabetes. Cell Biol. Toxicol. 2008; 24: 233-41.
48. Ravi K, Ramachandran B. Subramanian S. Protective effect of Eugenia jambolana seed kernel on tissue antioxidant in streptozotocin-induced diabetic rats. Biol. Pharm. 2004; 27: 1212-7.
49. Reynisdottir S, Angelin B, Langin D, Lithell H, Eriksson M, Holm C, et al Adipose tissue lipoprotein lipase and hormone sensitive lipase. Ateriosclerosis, Thrombosis Vasc. Biol. 1997; 17: 2287-92.
50. Ronco C, Grammaticopoulos S, Rosner M, Decal M, Soni, S, Lentini P, et al. Oliguria, creatinine and other biomarkers of acute kidney injury. Contributions Nephrol. 2010; 164: 118-27.
51. Ruperez FJ, Garcia-Martinez D, Baena B. Maeso, N, Cifuentes A, Barbas C. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 2008; 60: 871-8.
52. Sanders RA, Rausche FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocininduced diabetic rats. J Biochem Mol Toxicol. 2001; 15: 143-9.
53. Sekar SD, Sivagnanam K. Subramanian S. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats. Pharm. 2005; 60: 383-87.
54. Sekeroglu MR, Sahin H, Dulger H. Algun E. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase and glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin. Biochem. 2000; 33: 669-74.
55. Shamsi M. Amin A. Adeghate E. Vitamin e decreases the hyperglucagonemia of diabetic rats. Ann. N. Y.Acad. Sci. 2006; 1084: 432-41.
56. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh, GP. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metab. 2000; 49: 160-2.
57. Solano MPMD, Goldberg RBMD. Management of dyslipidemia in diabetes. Cardiology in Review. 2006; 14: 125-35.
58. Sout RW. Diabetes and athoresclerosis. Biomed. Pharmacother. 2005; 47: 1-2.
59. Stephen NJ. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries. Curr. Opin. Lipidol. 2004; 20: 491-96.
60. Szaleczky E, Prechi J, Ruzicska E, Fehér J, Braun, L., Bánhegyi A. Reduction of glycated hemoglobin levels by long term, high dose ascorbic acid supplementation in healthy and diabetic patients. Med. Sci. Monit. 1998; 4: 241-4.
61. Szkudeslski T. The Mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001; 50: 536-46.
62. Taniguchi N. Clinical significance of superoxide dismutases: changes in aging, diabetes, ischemia and cancer. Adv. Clin. Chem. 1992; 29: 1-59.
63. Unger RH, Orci L. Glucagon and the cell. II Physiology and Pathophysiology. N. Engl J. Med. 1981; 304: 1575-80.
64. Varvarovská J, Racek J, Stetina R, Sykora J, Pomahacová R. Rusavy Z. et al. Apects of oxidative stress in children with tpe 1 diabetes mellitus. Biomed. Pharmacother. 2004; 58: 539-45.
65. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol. 2004; 18: 234-8.
66. Young IS, Tate S, Lightbody JH, McMaster D. Trimble E.R. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Rad. Biol. Med. 1995; 18: 833-40.
67. Zar JH. Biostatistical Analysis. New Jersey: Prentice Ltd.; 1996.